Last updated on July 2019

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1 3 8 and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Brief description of study

This is a double-blind, multi-centre, randomised, 5-arm, vehicle-controlled, parallel-group trial. The trial is designed to establish a dose-response signal and to investigate the efficacy and safety of delgocitinib cream in the treatment of adult subjects with mild to severe chronic hand eczema.

Clinical Study Identifier: NCT03683719

Find a site near you

Start Over